Brain Tumor types

Brain Tumors: Decoding Impact on Surgery Success

The success of brain tumor surgery is intricately linked to diverse factors, encompassing tumor type, grade, location, patient age, overall health, and the proficiency of the surgical team. In this article, let’s accompany UpSurgeOn to delve into the nuanced landscape of brain tumors, shedding light on their impact on the success rates of surgical interventions.

1. Gliomas

Gliomas are a type of brain tumor that originates from glial cells, which are supportive cells in the brain. These tumors can be categorized into different grades, ranging from low-grade to high-grade tumors. Surgical resection is a common treatment approach for gliomas, particularly for low-grade tumors. The success of glioma surgery depends on various factors, including the grade and location of the tumor, the extent of resection, and the overall condition of the patient.

For low-grade gliomas, surgical resection plays a significant role in improving overall survival. Research has demonstrated that a greater extent of resection is associated with better outcomes and prolonged survival  [1] [2]. In fact, when the extent of resection is greater than 90%, low-grade gliomas have a 5-year survival rate of 97% and a 10-year survival rate of 91%.  [3]

On the other hand, high-grade gliomas, such as glioblastoma (Grade IV), have a poorer prognosis and are more aggressive. Despite this, surgery still plays a crucial role in managing high-grade gliomas. It can help alleviate symptoms, reduce tumor burden, and improve the quality of life for patients. However, the median survival for patients with high-grade gliomas is generally around 1 to 3 years, even with surgical resection. [3]

It is important to recognize that the success rate of glioma surgery can vary depending on individual factors and the specific characteristics of the tumor. Factors such as the patient’s age, functional status, and the presence of any neurological deficits can also influence surgical outcomes. Therefore, a multidisciplinary approach and personalized treatment plans are essential for glioma patients. [13]

2. Pituitary tumors

Hands-on training during Brain and Tumor Dissection Course
Hands-on training during Brain and Tumor Dissection Course. Source: UpSurgeOn

Pituitary tumors, abnormal growths that develop in the pituitary gland located at the base of the brain, can be classified as either functioning or non-functioning based on their hormone production capabilities. Surgical intervention is the primary method used to treat these tumors.

The success rate of surgical treatment for pituitary tumors can differ and is influenced by various factors. These factors include the tumor type, size, and the expertise of the surgeon performing the procedure. Transsphenoidal surgery, the preferred surgical technique for most pituitary tumors, has demonstrated a high success rate.

Studies have indicated that microadenomas, which are small tumors, can achieve a success rate of approximately 90%. Patients with non-functioning pituitary adenomas, acromegaly, thyrotropinomas, and Cushing’s disease are typically considered excellent candidates for primary surgical treatment. However, it is important to note that re-operations generally result in less favorable outcomes.

It is essential to understand that the success rate of surgical treatment may vary depending on the specific characteristics of the tumor and the individual patient. [47]

3. Meningiomas

Meningiomas are tumors that form in the protective membranes surrounding the brain and spinal cord, known as the meninges. While they are typically non-cancerous and slow-growing, there are instances where they can become malignant.

The success of surgical treatment for meningiomas depends on several factors, including the location, size, and extent of the tumor. Complete removal of the tumor, referred to as gross total resection (GTR), is associated with a lower risk of recurrence compared to partial removal. Studies have reported varying 10-year survival rates after surgery, ranging from 43% to 77%. The likelihood of recurrence within 10 years also varies, with rates ranging from 9% to 50% depending on the extent of resection and the tumor’s histopathological features. [8]

It is crucial to acknowledge that surgery for meningiomas carries potential risks and complications, including a surgical mortality rate as high as 14.3% [8]. Therefore, the decision to undergo surgery should consider the individual patient’s unique circumstances and weigh the potential risks and benefits of the procedure.

4. Acoustic neuroma 

Hands-on training during Brain and Tumor Dissection Course
Hands-on training during Brain and Tumor Dissection Course. Source: UpSurgeOn

Acoustic neuroma, also known as vestibular schwannoma, is a noncancerous growth that develops on the vestibulocochlear nerve, responsible for both balance and hearing. This tumor originates from Schwann cells, which play a crucial role in supporting and insulating nerve fibers.

The success of surgical treatment for acoustic neuroma depends on several factors, including the size and location of the tumor as well as the surgical approach employed. The effectiveness of the procedure is typically evaluated based on the extent of tumor removal, the preservation of neurological function, and the prevention of tumor recurrence.

A comprehensive study examining the surgical management of 1000 vestibular schwannomas found that the suboccipital transmeatal approach resulted in complete tumor removal in 979 cases out of 1000. Furthermore, 93% of patients achieved anatomical preservation of the facial nerve, while 68% experienced preservation of the cochlear nerve [9].

Another study investigating the long-term outcomes of microsurgical resection for acoustic neuromas reported a tumor control rate of 98%. Within this group, 62% of tumors decreased in size, while 33% remained unchanged. Additionally, 79% of patients maintained facial function after five years, and 51% experienced no change in hearing ability [10].

It is crucial to acknowledge that surgical outcomes can vary based on the surgeon’s expertise, patient characteristics, and the specific surgical technique employed. Moreover, each patient’s case is unique, and individual factors may influence the success rate. Therefore, it is essential to determine the most suitable treatment approach for acoustic neuroma.

5. Medulloblastoma

Medulloblastoma is a specific type of brain tumor that primarily affects children, although it can also occur in adults. This tumor originates in the cerebellum, which is responsible for maintaining balance and coordination in the brain. Medulloblastomas are known for their rapid growth and ability to spread to other areas of the brain and spinal cord.

The success of surgical treatment for medulloblastoma depends on several factors, including the extent of tumor removal and the presence of metastases. Research has indicated that complete or near-complete removal of the tumor is associated with better outcomes and higher survival rates. However, removing the tumor completely can be challenging in cases where it has invaded the brainstem [11].

In children, the overall 5-year survival rate for medulloblastoma ranges from 27.7% to 60%, depending on the extent of tumor removal and the use of additional treatments like radiotherapy and chemotherapy [12] [13]. For adults, the reported 5-year survival rates range from 50% to 80% [14] [15].

It is important to understand that these survival rates are based on studies conducted over different time periods and may vary depending on individual patient characteristics and treatment approaches. To improve outcomes and develop targeted therapies for medulloblastoma, it is crucial for healthcare professionals to collaborate closely and for ongoing research to be conducted [16].

6. Metastatic Brain Tumor 

Brain Tumor Detection during the Brain and Tumor Dissection course. Source: UpSurgeOn

Metastatic brain tumors are a common occurrence, affecting 10%-40% of cancer patients. These tumors originate from cancer in other parts of the body and spread to the brain. Surgical treatment has proven to be effective in improving overall survival and quality of life for patients with metastatic brain tumors.

The success rate of surgical treatment varies depending on several factors. These include the type of primary cancer, the number and location of brain metastases, and the overall health of the patient. However, surgical resection is generally considered a safe and effective procedure for treating cerebral metastases.

A study conducted on patients with brain metastases from various primary tumors revealed that more than half of the patients (55%) survived for more than 6 months after surgery. This significant improvement in survival exceeded expectations [17].

Another study focused specifically on patients with hemorrhagic metastatic brain tumors. It found that surgery was a favorable treatment option, with a low recurrence rate and an impressive 12-month progression-free survival rate of 86.1% [18].

In the case of sarcoma metastatic to the brain, surgical treatment has shown promising results. Patients who underwent craniotomy had a median survival of 11.8 months. A complete resection of the tumor and a good performance score were associated with a favorable prognosis [19].

It is important to consider surgical treatment in conjunction with other treatment modalities, such as radiation therapy and chemotherapy, depending on the individual patient’s case. The success of surgical treatment may also depend on the overall management of the primary cancer and the control of systemic disease.

Conclusion 

The success of brain tumor surgery relies on various factors, including the type, grade, and location of the tumor, as well as the unique traits of each patient and the proficiency of the surgeon. To ensure the best possible treatment plan, it is crucial to take into account all relevant aspects and personalize the approach. Collaboration among healthcare professionals is also vital in navigating the complexities of surgical outcomes. By integrating cutting-edge research, refining treatment strategies, and striving for improved success rates and patient outcomes, we can better understand the intricate relationship between surgical interventions and the diverse landscape of brain tumors.

At UpSurgeOn, we believe in revolutionizing the field of brain tumor surgery. Our advanced surgical simulation technologies empower surgeons to enhance their skills with confidence and precision. Join us on this transformative journey as we unveil the power of surgical simulation. Visit our website and embark on an adventure that will keep you at the forefront of the dynamic world of surgery!


References: 

  1. Ius, T., Isola, M., Budai, R., Pauletto, G., Tomasino, B., Fadiga, L., & Škrap, M. (2012). Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients. Journal of Neurosurgery, 117(6), 1039–1052. https://doi.org/10.3171/2012.8.jns12393
  2. Ius, T., Ng, S., Young, J. S., Tomasino, B., Polano, M., Ben‐Israel, D., Kelly, J. J., Škrap, M., Duffau, H., & Berger, M. S. (2021). The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study. Neuro-oncology, 24(4), 624–638. https://doi.org/10.1093/neuonc/noab210
  3. Hervey-Jumper, S., & Berger, M. S. (2014). Role of surgical resection in Low- and High-Grade Gliomas. Current Treatment Options in Neurology, 16(4). https://doi.org/10.1007/s11940-014-0284-7
  4. Buchfelder, M., & Schlaffer, S. (2009). Surgical treatment of pituitary tumours. Best Practice & Research Clinical Endocrinology & Metabolism, 23(5), 677–692. https://doi.org/10.1016/j.beem.2009.05.002
  5. Loyo-Varela, M., Herrada-Pineda, T., Revilla-Pacheco, F., & Manrique-Guzmán, S. (2013). Pituitary tumor surgery: Review of 3004 cases. World Neurosurgery, 79(2), 331–336. https://doi.org/10.1016/j.wneu.2012.06.024
  6. Almeida, J. P., Tabasinejad, R., Kalyvas, A., Takami, H., Mohan, N., O’Halloran, P. J., Sánchez, M. M., Velásquez, C., Zadeh, G., & Gentili, F. (2020). The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence. PubMed, 68(Supplement), S92–S100. https://doi.org/10.4103/0028-3886.287675
  7. Mortini, P., Losa, M., Barzaghi, L. R., Boari, N., & Giovanelli, M. (2005). Results of Transsphenoidal Surgery in a Large Series of Patients with Pituitary Adenoma. Neurosurgery, 56(6), 1222–1233. https://doi.org/10.1227/01.neu.0000159647.64275.9d
  8. Black, P. M. (1993). Meningiomas. Neurosurgery, 32(4), 643–657. https://doi.org/10.1227/00006123-199304000-00023
  9. Samii, M., & Matthies, C. (1997). Management of 1000 Vestibular Schwannomas (Acoustic Neuromas): Surgical Management and Results with an Emphasis on Complications and How to Avoid Them. Neurosurgery, 40(1), 11–23. https://doi.org/10.1097/00006123-199701000-00002
  10. Kondziolka, D., Lunsford, L. D., McLaughlin, M. R., & Flickinger, J. C. (1998). Long-Term Outcomes after Radiosurgery for Acoustic Neuromas. The New England Journal of Medicine, 339(20), 1426–1433. https://doi.org/10.1056/nejm199811123392003
  11. Yılmaz, H., Akçay, E., & Benek, H. (2021). Medulloblastoma in adults: surgical outcomes and survival- a single center analysis of 16 patients. Turkish Neurosurgery. https://doi.org/10.5137/1019-5149.jtn.32143-20.2
  12. Gökalp, H., Arasil, E., Kanpolat, Y., Erdogan, A., Deda, H., & Ünlü, A. (1993). Medulloblastomas*. Minimally Invasive Neurosurgery, 36(03), 87–89. https://doi.org/10.1055/s-2008-1053802
  13. Mazza, C., Pasqualin, A., Da Pian, R., & Donati, E. (1981). Treatment of medulloblastoma in children: Long-term results following surgery, radiotherapy and chemotherapy. Acta Neurochirurgica, 57(3–4), 163–175. https://doi.org/10.1007/bf01664835
  14. Eibl, T., Hammer, A., Yakubov, E., Blechschmidt, C., Kalisch, A., & Steiner, H. (2021). Medulloblastoma in adults – reviewing the literature from a surgeon’s point of view. Aging, 13(2), 3146–3160. https://doi.org/10.18632/aging.202568
  15. Abacıoğlu, U., Uzel, Ö., Şengöz, M., Türkan, S., & Öber, A. (2002). Medulloblastoma in adults: treatment results and prognostic factors. International Journal of Radiation Oncology Biology Physics, 54(3), 855–860. https://doi.org/10.1016/s0360-3016(02)02986-3
  16. Gentet, J. C., Genitori, L., Mancini, J., Bernard, J. L., Coze, C., Nicolas, C., & Raybaud, C. (1991, March). Medulloblastoma in children. Current treatments and future perspectives. In Annales de Pediatrie (Vol. 38, No. 3, pp. 137-141).
  17. D’Andrea, G., Palombi, L., Minniti, G., Pesce, A., & Marchetti, P. (2017b). Brain metastases: surgical treatment and overall survival. World Neurosurgery, 97, 169–177. https://doi.org/10.1016/j.wneu.2016.09.054
  18. Yoo, H., Jung, E. J., Gwak, H. S., Shin, S. H., & Lee, J. Y. (2011). Surgical outcomes of hemorrhagic metastatic brain tumors. Cancer Research and Treatment, 43(2), 102–107. https://doi.org/10.4143/crt.2011.43.2.102
  19. Bindal, R. K., Sawaya, R., Leavens, M. E., Taylor, S. H., & Guinee, V. F. (1994). Sarcoma metastatic to the brain. Neurosurgery, 35(2), 185–191. https://doi.org/10.1227/00006123-199408000-00002
  20. Boström, A., Von Lehe, M., Hartmann, W., Pietsch, T., Feuss, M., Boström, J., Schramm, J., & Simon, M. (2011). Surgery for spinal cord ependymomas: Outcome and prognostic factors. Neurosurgery, 68(2), 302–309. https://doi.org/10.1227/neu.0b013e3182004c1e

Mastering simple interrupted dural closure with Mycro

Mastering continous dural closure with Mycro

Mastering the Horizontal Mattress Suture

Beyond the Basics: Simple buried suture